BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29668751)

  • 1. Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis.
    Li W; Luo X; Liu Z; Chen Y; Li Z
    PLoS One; 2018; 13(4):e0195769. PubMed ID: 29668751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
    Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
    Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
    Gao N; Yang RN; Meng Z; Wang WH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
    Jin J; Hu K; Zhou Y; Li W
    PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
    Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
    Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.
    Yi JH; Wang D; Li ZY; Hu J; Niu XF; Liu XL
    PLoS One; 2014; 9(5):e94632. PubMed ID: 24800842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of pre-therapy C-reactive protein level in diffuse large B-cell lymphoma: a meta-analysis.
    Qin W; Yuan Q; Wu J; Yu H; Wang Y; Chen Q
    Leuk Lymphoma; 2019 Feb; 60(2):358-366. PubMed ID: 30033839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies.
    Jin J; Hu K; Zhou Y; Li W
    Int J Biol Markers; 2018 May; 33(2):201-207. PubMed ID: 29076522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of C-reactive protein in patients with nasopharyngeal carcinoma: A meta-analysis and literature review.
    Fang Y; Xu C; Wu P; Zhang LH; Li DW; Sun JH; Li WF; Liao ZS
    Medicine (Baltimore); 2017 Nov; 96(45):e8463. PubMed ID: 29137033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
    Zhang W; Zhang Z; Qian L
    World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.
    Wang X; Liu S; Zhao X; Fang E; Zhao X
    PLoS One; 2019; 14(7):e0219215. PubMed ID: 31260491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein: An independent predictor for dedifferentiated chondrosarcoma.
    Nemecek E; Funovics PT; Hobusch GM; Lang S; Willegger M; Sevelda F; Brodowicz T; Stihsen C; Windhager R; Panotopoulos J
    J Orthop Res; 2018 Oct; 36(10):2797-2801. PubMed ID: 29701260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
    Liu Z; Shi H; Chen L
    BMC Cancer; 2019 Nov; 19(1):1161. PubMed ID: 31783812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
    Chen J; Sun MX; Hua YQ; Cai ZD
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.
    Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
    Tumour Biol; 2015 Sep; 36(10):7515-20. PubMed ID: 25913621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
    Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
    BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.